双極性障害の患者における血清ZO-1およびオークルジンのレベル
Pınar Aydogan Avşar1, Merve Akkuş2
1Department of Child and Adolescent Psychiatry, Alanya Alaaddın Keykubat Unıversıty Training And Research Hospıtal, Alanya, Antalya, Turkey.
European archives of psychiatry and clinical neuroscience
|September 1, 2025
まとめ
血中脳障壁タンパク質オクラジンとゾヌラオクラデンス-1タンパク質 (ZO-1) の血清濃度は双極性障害の患者で上昇した. これは,血脳障壁の障害が双極性障害に寄与する可能性があることを示唆しています.
科学分野:
- 神経科学
- 精神科
- 生物化学
背景:
- 双極性障害 (BD) の病因は複雑である.
- 血脳障壁 (BBB) は,緊密な結節 (TJs) を通して,中枢神経系 (CNS) を保護する.
- TJタンパク質の整合性は健康的なBBB機能に不可欠です.
研究 の 目的:
- 双極性障害の患者におけるTJタンパク質オクラウジンとゾヌラオクラウデンス-1タンパク質 (ZO-1) の血清濃度を調べる.
- 双極性障害のエチオパトゲネシスにおける BBB 整合性の役割を調査する.
- BDにおけるBBB漏れの可能性のあるバイオマーカーを特定する.
主な方法:
- 40人のBD患者 (マニアとエウティミアのエピソード) と40人の健康な対照群の血清オクラジンとZO-1濃度を比較した.
- 集団の違いを評価するために,共変量分析 (ANCOVA) を利用した.
- 年齢,性別,BMI,喫煙状況がチェックされます.
主要な成果:
- 血清オクラディンとZO-1濃度は対照群と比較して,双極性障害の患者で有意に高かった.
- ANCOVAは,血清オークルジンとZO-1濃度に対するグループの有意な主要効果を確認した.
- これらの結果は,年齢,性別,BMI,喫煙とは無関係でした.
結論:
- 血清オークルジニンとZO-1の値上昇は,双極性障害における血脳障壁の障害を示唆する.
- BBB機能障害と神経炎症は,BDの病原発生に関与している可能性があります.
- オックルジンとZO-1は,BDにおけるBBB漏出のバイオマーカーとして潜在的に示され,将来の治療法に情報を与えることができる.
関連する概念動画
Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Negative and Cognitive Symptoms of Schizophrenia
120
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
120
Depressive Disorders: Etiology
165
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
165
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
945
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
945
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209


